Valuation: Ambee Pharmaceuticals Plc

Market Cap 1.82B 14.73M 12.88M 11.88M 10.92M 20.7M 1.42B 21.05M 142M 55.67M 693M 55.33M 54.12M 2.39B P/E 2024
189x
P/E 2025 369x
Enterprise Value 2.32B 18.84M 16.47M 15.2M 13.97M 26.47M 1.81B 26.92M 181M 71.19M 886M 70.77M 69.21M 3.05B EV / Sales 2024
10.4x
EV / Sales 2025 10.7x
Free-Float
22.75%
Yield 2024
0.13%
Yield 2025 0.12%
1 day+4.03%
1 week+7.65%
Current month+8.78%
1 month+7.78%
3 months+8.38%
6 months+15.98%
Current year+16.23%
1 week 757
Extreme 757
833
1 month 750
Extreme 750
833
Current year 689
Extreme 689
833
1 year 681
Extreme 681
909
3 years 511
Extreme 511
1,302.3
5 years 375.3
Extreme 375.3
1,302.3
10 years 294.5
Extreme 294.5
1,302.3
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Chief Administrative Officer - -
Director TitleAgeSince
Chairman - -
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+4.03%+7.65%-8.01%+53.35% 15.41M
-0.07%+3.28%+12.89%+81.75% 48.66B
+0.59%-1.21%+67.38%+116.30% 35.52B
-0.59%-0.16%-4.12%+38.67% 12.07B
-0.26%+0.51%+19.25%+93.82% 11.99B
+1.13%+1.15%+32.83%+126.50% 9.29B
-1.76%-5.73%+41.23%-7.49% 6.92B
+0.50%+0.58%+19.74%+38.26% 7B
-0.46%+2.84%+2.73%+225.72% 6.74B
+7.04%+14.92%-10.65%+29.12% 6.36B
Average +0.99%+2.25%+17.33%+79.60% 14.46B
Weighted average by Cap. +0.34%+1.28%+26.84%+88.53%

Financials

2024 2025
Net sales 219M 1.78M 1.56M 1.44M 1.32M 2.5M 171M 2.54M 17.14M 6.72M 83.7M 6.68M 6.54M 289M 231M 1.87M 1.64M 1.51M 1.39M 2.63M 180M 2.67M 18.02M 7.07M 88M 7.03M 6.87M 303M
Net income 9.68M 78.59K 68.71K 63.38K 58.26K 110K 7.56M 112K 757K 297K 3.7M 295K 289K 12.74M 5.31M 43.09K 37.67K 34.75K 31.95K 60.53K 4.15M 61.57K 415K 163K 2.03M 162K 158K 6.98M
Net Debt 445M 3.61M 3.16M 2.91M 2.68M 5.07M 347M 5.16M 34.75M 13.63M 170M 13.55M 13.26M 585M 506M 4.11M 3.59M 3.31M 3.05M 5.77M 395M 5.87M 39.56M 15.52M 193M 15.43M 15.09M 666M
Logo Ambee Pharmaceuticals Plc
Ambee Pharmaceuticals Plc is a Bangladesh-based company. The business of the Company is to manufacture, buy, sell, export, or deal in all kinds of drugs, medicines, pharmaceuticals, chemicals, medical or any other preparations. It refines, manipulates or treats all such substances used in the pharmaceutical industry. The Company offers tablets, capsules, liquids, gel in tubes, and injectables. Its products include ANTAC, LAP, OM-20, OM-40, STOMACID, AMBEECLOX, AMBEEXIN, FLUXIN, MYCEF, MYCEF-DS, TRICEF, A-ROX, MYCIN, MYZID, HIFLOX, HIFLOX-XR, LEXLO, DOXILLIN, TETRAM, TACTIN, NALIDEX, AFLUZOLE, AFUVIN, KLION, AMETROL-VT, TRIBEN-DS, TRIBEN, SURAL, MESPA, NO-SPA, AMINOPHYLLINE, CODEX, DEXTROMETHORPHAN, NILKOF, ACES PLUS, AMBEECAL, AMBEECAL D, ACT, ACT PLUS, AROLAK, AROLAK-10, AROLAK30, HITFLAM, HITFLAM-SR, NAPROXIN, CINON, FUNGAKIL, AMASON, PREDNISOLONE, NOSTIS, ALUCTIN, NOCTIN, SEDUXEN, and PERO-L. The Company has approximately nine sales centers in all over Bangladesh.
Employees
474
Date Price Change Volume
16/07/26 BDT 822.90 +4.03% 12,480
15/07/26 BDT 791.00 +2.51% 5,963
14/07/26 BDT 771.60 +0.38% 1,683
13/07/26 BDT 768.70 +1.48% 1,750
12/07/26 BDT 757.50 -0.42% 122
  1. Stock Market
  2. Stocks
  3. AMBEEPHA Stock